Persist AI, an AI-driven robotics platform for the pharmaceutical industry, announced an overscribed $12 million Series A funding round.Spero Ventures led the round with participation from MBX Capital, Shimadzu Future Innovation Fund managed by…
Continue Reading
Persist AI, an AI-driven robotics platform for the pharmaceutical industry, announced an overscribed $12 million Series A funding round.Spero Ventures led the round, with participation from MBX Capital, Shimadzu Future Innovation Fund managed by…
Continue Reading
Revolutionary Shift in Research Methodology
The National Institutes of Health (NIH) has announced a transformative program designed to expand innovative, human-based science while decreasing animal use in research. This landmark initiative acknowledges that while traditional…
Raj Indupuri, CEO and Co-Founder of eClinical Solutions
For years, the life sciences industry has been trying to address the same R&D challenges: rising costs, patient recruitment and retention, and difficulty maximizing ROI. Drug development is expensive,…
Continue Reading
Clinical trials are an essential component of drug development for new cancer treatments, yet the information required to determine a patient’s eligibility for enrollment is scattered in large amounts of unstructured text. Genomic biomarkers…
Continue Reading
Data sharing technology company Datavant has expanded its collaboration with pharmaceutical company Boehringer Ingelheim to support Boehringer’s real-world evidence initiatives. The extended collaboration aims to leverage Datavant’s privacy-preserving tokenization and data connectivity technologies to strengthen…
Continue Reading
What You Should Know:
– Precision for Medicine, a provider of next-generation drug development research and services, and PathAI, a global leader in digital pathology, announced a strategic collaboration today.
– The partnership aims to jointly…
Continue Reading
The Evolving Orphan Drug Landscape
Once considered specialized treatments for rare conditions, orphan drugs are now challenging the dominance of mainstream medications in the pharmaceutical industry. According to two recent Evaluate reports—”Are Orphans That Different?”…
Rajneesh Patil Vice President, Digital Innovation at IQVIA
Nicholas Whitney, Senior Director, Site Suite, IQVIA Technologies
In recent years, clinical research and development stakeholders have put tremendous effort into improving patient-centered clinical trials, where patients feel…
Continue Reading
Source: Icahn School of Medicine at Mount Sinai
What You Should Know:
– The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a pioneering initiative that leverages…
Continue Reading
